sCD80‐Fc overcame PDL1‐mediated suppression in human or mouse tumor cells, facilitating T cell activation by binding to PDL1 to inhibit PDL1:PD1 interaction and by co‐stimulation via CD28.22, 23. Here, CD274 is linked to neoplasm.